Logic Gate Nanocarriers for Targeted Drug Release
Solution Overview
Problem
Current nanoparticle systems face challenges in targeting inflammation and achieving controlled cytoplasmic delivery, with existing pH-responsive polymers experiencing slow degradation rates and stability issues at physiological pH, and rapid acid-catalyzed hydrolysis leading to inflammatory side effects, while gene delivery faces challenges with nuclease degradation and low transfection efficiency.
Innovation Solution
Development of logic gate nanocarriers with dual-response mechanisms, comprising polymers that become more hydrophilic in response to lower pH and ROS, allowing for rapid and controlled degradation and release of bioactive agents, and encapsulation of DNA using pH-responsive polymers to enhance gene delivery efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If pH-responsive polymers are used for nanoparticle degradation, then rapid acid-catalyzed hydrolysis is achieved, but inflammatory side effects occur
Solution Approach 1:
The patent changes the chemical parameter of the polymer backbone from traditional ester bonds to polyketals and polyorthoesters, which have different hydrolysis kinetics and pH sensitivity profiles. This allows rapid degradation at acidic pH while producing non-inflammatory byproducts (acetone and alcohols instead of carboxylic acids), resolving the contradiction between fast degradation and inflammatory side effects
Solution Approach 2:
The patent incorporates oxidation-sensitive thioether bonds into the polymer backbone that are cleaved by reactive oxygen species (ROS) at the disease site. This dual-mechanism (acid catalysis and oxidation) accelerates degradation specifically at the target site while minimizing systemic inflammatory responses, as the oxidation pathway produces non-inflammatory sulfur-containing byproducts
2Stability of the object's composition
If nanoparticles are designed for stable circulation, then serum stability is enhanced, but controlled release at target site is reduced
Solution Approach 1:
The patent designs polymers with dual-responsive parameters: stable at physiological pH 7.4 but rapidly degradable at acidic pH <6.5 and in presence of ROS. The polyketal and polyorthoester backbones maintain structural integrity in serum while undergoing rapid hydrolysis at the acidic tumor microenvironment, achieving both stable circulation and controlled release
Solution Approach 2:
The patent creates dynamically responsive nanoparticles that adapt their stability based on environmental conditions. The particles remain stable during circulation in blood (pH 7.4, low ROS) but dynamically switch to rapid degradation when encountering the acidic, high-ROS tumor microenvironment, enabling spatiotemporal control over drug release
3Quantity of substance
If DNA is delivered systemically, then gene delivery coverage is improved, but nuclease degradation increases
Solution Approach 1:
The patent encapsulates DNA within the nanoparticle core, nesting the genetic material inside a protective polymeric shell. This nested structure physically shields DNA from nucleases during circulation while allowing systematic delivery to multiple tissues. The nanoparticle acts as a protective container that maintains DNA integrity throughout the bloodstream journey
4Stability of the object's composition
If polyesters are used for nanoparticle synthesis, then biodegradability is achieved, but slow degradation rates and acidic byproducts occur
Solution Approach 1:
The patent fundamentally changes the chemical composition of the degradable bonds in the polymer backbone, replacing ester linkages with polyketal and polyorthoester linkages. This chemical parameter change transforms the degradation mechanism from slow ester hydrolysis producing carboxylic acids to rapid ketal/orthoester hydrolysis producing non-acidic byproducts (acetone and alcohols), achieving both biodegradability and fast degradation rates
Solution Approach 2:
The patent converts the typically harmful acidic degradation byproducts of polyesters into beneficial non-acidic byproducts. By using polyketal and polyorthoester backbones, the degradation produces acetone and alcohols instead of carboxylic acids, eliminating the inflammatory side effects while maintaining rapid biodegradability, thus turning a harmful characteristic into a beneficial one
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The logic gate nanocarriers provide targeted and controlled release of bioactive agents at diseased sites, minimizing systemic exposure and side effects, and improve gene delivery by protecting DNA from nuclease degradation and enhancing transfection efficiency.
Implementation Method 1
comprising polymers that become more hydrophilic in response to lower pH
Implementation Method 2
comprising polymers that become more hydrophilic in response to lower pH and ROS
Implementation Method 3
rapid acid-catalyzed hydrolysis
Data Source
AI summary
Nanocarriers are synthesized with polymers that respond to lower pH and/or ROS by being degraded. The compositions may be utilized to selectively deliver payloads within patients by responding to lower pH and/or ROS at localities within the patient. The present invention also features methods of synthesizing nanocarriers that are degraded by lower pH and/or ROS.